{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T02:22:33Z","timestamp":1769307753885,"version":"3.49.0"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2022,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>A 27-year-old woman with known malignant pheochromocytoma was enrolled in a clinical trial to compare efficacy of <jats:sup>68<\/jats:sup>Ga-DOTATATE PET\/CT and <jats:sup>18<\/jats:sup>F-MFBG PET\/CT. Images from both studies detected similar number of the metastatic lesions. In addition, both studies detected more lesions than <jats:sup>131<\/jats:sup>I-MIBG imaging.<\/jats:p>","DOI":"10.1097\/rlu.0000000000003997","type":"journal-article","created":{"date-parts":[[2022,1,12]],"date-time":"2022-01-12T18:04:37Z","timestamp":1642010677000},"page":"451-453","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":13,"title":["Similar Findings on 18F-MFBG PET\/CT and 68Ga-DOTATATE PET\/CT in a Patient With Widespread Metastatic Pheochromocytoma"],"prefix":"10.1097","volume":"47","author":[{"given":"Peipei","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guozhu","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongli","family":"Jing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongming","family":"Zhuang","sequence":"additional","affiliation":[{"name":"Department of Radiology, Children's Hospital of Philadelphia University of Pennsylvania Perelman School of Medicine, Philadelphia, PA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,1,10]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0140-6736(05)67139-5","article-title":"Phaeochromocytoma","volume":"366","year":"2005","journal-title":"Lancet"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2967\/jnumed.108.058693","article-title":"99mTc-HYNIC-TOC scintigraphy is superior to 131I-MIBG imaging in the evaluation of extraadrenal pheochromocytoma","volume":"50","year":"2009","journal-title":"J Nucl Med"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"B45","DOI":"10.1007\/s00259-003-1138-9","article-title":"Guidelines for radioiodinated MIBG scintigraphy in children","volume":"30","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/RLU.0000000000001984","article-title":"SPECT\/CT MIBG imaging is crucial in the follow-up of the patients with high-risk neuroblastoma","volume":"43","year":"2018","journal-title":"Clin Nucl Med"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00259-020-04830-x","article-title":"Improved resolution and sensitivity of [18F]MFBG PET compared with [123I]MIBG SPECT in a patient with a norepinephrine transporter-expressing tumour","volume":"48","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/RLU.0000000000001674","article-title":"Comparison of the 68Ga-DOTATATA PET\/CT, FDG PET\/CT, and MIBG SPECT\/CT in the evaluation of suspected primary pheochromocytomas and paragangliomas","volume":"42","year":"2017","journal-title":"Clin Nucl Med"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1053\/j.semnuclmed.2016.01.011","article-title":"I-131 metaiodobenzylguanidine therapy of pheochromocytoma and paraganglioma","volume":"46","year":"2016","journal-title":"Semin Nucl Med"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/CCO.0000000000000691","article-title":"131I-metaiodobenzylguanidine and peptide receptor radionuclide therapy in pheochromocytoma and paraganglioma","volume":"33","year":"2021","journal-title":"Curr Opin Oncol"},{"key":"bib9-20250621","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s13139-018-0523-z","article-title":"Current consensus on I-131 MIBG therapy","volume":"52","year":"2018","journal-title":"Nucl Med Mol Imaging"},{"key":"bib10-20250621","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1530\/EJE-18-0901","article-title":"Treatment of inoperable or metastatic paragangliomas and pheochromocytomas with peptide receptor radionuclide therapy using 177Lu-DOTATATE","volume":"181","year":"2019","journal-title":"Eur J Endocrinol"},{"key":"bib11-20250621","doi-asserted-by":"crossref","first-page":"100171","DOI":"10.1016\/j.esmoop.2021.100171","article-title":"Peptide receptor radionuclide therapy in patients with metastatic progressive pheochromocytoma and paraganglioma: long-term toxicity, efficacy and prognostic biomarker data of phase II clinical trials","volume":"6","year":"2021","journal-title":"ESMO Open"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003997","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T20:03:30Z","timestamp":1750536210000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,10]]},"references-count":11,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000003997","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1,10]]}}}